CD47 is a cell surface receptor that regulates macrophages from attacking healthy cells and is known to be overexpressed in cancers (13); B2M is a marker on MHC class 1 molecules (9); and EPCAM is a transmembrane receptor on epithelial cells that aids cell adhesion (14). Here, CD177 is linked to cancer.